Back
Autolus Therapeutics PLC Stock Price Chart
Sponsored
AUTL
Sponsored
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
22
AUTL
Autolus Therapeutics PLC
Last Price:
$2.29
Seasonality Move:
-14.07%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing slight buying pressure.
Autolus Therapeutics PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.5 | Sell |
20-day SMA: | 2.84 | Sell |
50-day SMA: | 3.41 | Sell |
200-day SMA: | 4.1 | Sell |
8-day EMA: | 2.48 | Sell |
20-day EMA: | 2.77 | Sell |
50-day EMA: | 3.19 | Sell |
200-day EMA: | 3.86 | Sell |
Autolus Therapeutics PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 28.9 | Sell |
Chaikin Money Flow: | 521617 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 3.16) | Sell |
Bollinger Bands (100): | (3.08 - 4.24) | Sell |
Autolus Therapeutics PLC Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Autolus Therapeutics PLC Stock
Is Autolus Therapeutics PLC Stock a Buy?
-
Autolus Therapeutics PLC share price is 2.29 while AUTL 8-day simple moving average is 2.50, which is a Sell signal.
-
The stock price of AUTL is 2.29 while Autolus Therapeutics PLC 20-day SMA is 2.84, which makes it a Sell.
-
Autolus Therapeutics PLC 50-day simple moving average is 3.41 while AUTL share price is 2.29, making it a Sell technically.
-
AUTL stock price is 2.29 and Autolus Therapeutics PLC 200-day simple moving average is 4.10, creating a Sell signal.
AUTL Technical Analysis vs Fundamental Analysis
Sell
22
Autolus Therapeutics PLC (AUTL)
is a Sell
Is Autolus Therapeutics PLC a Buy or a Sell?
-
Autolus Therapeutics PLC stock is rated a SellThe current Autolus Therapeutics PLC [AUTL] share price is $2.29. The Score for AUTL is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Autolus Therapeutics PLC Stock Info
Market Cap:
609.4M
Price in USD:
2.29
Share Volume:
2.6M
Autolus Therapeutics PLC 52-Week Range
52-Week High:
7.45
52-Week Low:
2.20
Sell
22
Autolus Therapeutics PLC (AUTL)
is a Sell
Autolus Therapeutics PLC Share Price Forecast
-
What is the Autolus Therapeutics PLC stock price today?The Autolus Therapeutics PLC stock price is 2.29 USD today.
-
Will AUTL stock go up or go down?Autolus Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Autolus Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Autolus Therapeutics PLC is overvalued.
Is Autolus Therapeutics PLC Stock a Buy?
-
Autolus Therapeutics PLC share price is 2.29 while AUTL 8-day exponential moving average is 2.48, which is a Sell signal.
-
The stock price of AUTL is 2.29 while Autolus Therapeutics PLC 20-day EMA is 2.77, which makes it a Sell.
-
Autolus Therapeutics PLC 50-day exponential moving average is 3.19 while AUTL share price is 2.29, making it a Sell technically.
-
AUTL stock price is 2.29 and Autolus Therapeutics PLC 200-day simple moving average is 3.86, creating a Sell signal.
Fundamental Analysis of Autolus Therapeutics PLC
Is Autolus Therapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.11 per share.
Technical Analysis of Autolus Therapeutics PLC
Should I short Autolus Therapeutics PLC stock?
-
AUTL Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Autolus Therapeutics PLC is a Sell
-
Autolus Therapeutics PLC Relative Strength Index (RSI) is 28.9, which suggest Autolus Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Autolus Therapeutics PLC is (2.56 - 3.16), which suggest Autolus Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Autolus Therapeutics PLC is (3.08 - 4.24), which suggest Autolus Therapeutics PLC is a Sell
* Autolus Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.